K Anastos

Summary

Publications

  1. ncbi request reprint Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease
    Kathryn Anastos
    Department of Internal Medicine, Montefiore Medical Center and Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA
    Arch Intern Med 162:1973-80. 2002
  2. ncbi request reprint Association of race and gender with HIV-1 RNA levels and immunologic progression
    K Anastos
    Montefiore Medical Center, Bronx, New York 10467, USA
    J Acquir Immune Defic Syndr 24:218-26. 2000
  3. ncbi request reprint Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS)
    K Anastos
    Montefiore Medical Center, Bronx, New York, USA
    J Acquir Immune Defic Syndr 21:141-7. 1999
  4. ncbi request reprint HIV status, trust in health care providers, and distrust in the health care system among Bronx women
    C O Cunningham
    Montefiore Medical Center Albert Einstein College of Medicine, Bronx, New York 10467, USA
    AIDS Care 19:226-34. 2007
  5. pmc Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women
    Howard D Strickler
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    J Infect Dis 197:319-27. 2008
  6. ncbi request reprint Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    J Womens Health (Larchmt) 15:591-8. 2006
  7. pmc Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study
    Joseph G Feldman
    SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, USA
    Am J Public Health 96:1060-5. 2006
  8. pmc Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
    Carlos M Vaamonde
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 22:222-31. 2006
  9. ncbi request reprint Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure
    Stephen J Gange
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 41:68-74. 2006
  10. pmc Increased circulating interleukin-7 levels in HIV-1-infected women
    Laura A Napolitano
    Gladstone Institute of Virology and Immunology, University of California at San Francisco, 94158, USA
    J Acquir Immune Defic Syndr 40:581-4. 2005

Collaborators

Detail Information

Publications65

  1. ncbi request reprint Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease
    Kathryn Anastos
    Department of Internal Medicine, Montefiore Medical Center and Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA
    Arch Intern Med 162:1973-80. 2002
    ..The optimal virologic and immunologic stage at which to initiate antiretroviral therapy in individuals infected with human immunodeficiency virus type 1 (HIV-1) is undefined...
  2. ncbi request reprint Association of race and gender with HIV-1 RNA levels and immunologic progression
    K Anastos
    Montefiore Medical Center, Bronx, New York 10467, USA
    J Acquir Immune Defic Syndr 24:218-26. 2000
    ..HIV-1 RNA and lymphocyte subset levels are the principal indications for antiretroviral treatment. Past reports have differed with regard to the effect of gender and race on these measures and in measures of disease progression...
  3. ncbi request reprint Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS)
    K Anastos
    Montefiore Medical Center, Bronx, New York, USA
    J Acquir Immune Defic Syndr 21:141-7. 1999
    ....
  4. ncbi request reprint HIV status, trust in health care providers, and distrust in the health care system among Bronx women
    C O Cunningham
    Montefiore Medical Center Albert Einstein College of Medicine, Bronx, New York 10467, USA
    AIDS Care 19:226-34. 2007
    ..Studies are needed to understand how trust in providers and the health care system is achieved and maintained, and how trust is correlated with HIV-related health outcomes...
  5. pmc Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women
    Howard D Strickler
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    J Infect Dis 197:319-27. 2008
    ....
  6. ncbi request reprint Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    J Womens Health (Larchmt) 15:591-8. 2006
    ..To describe menstrual abnormalities among women with HIV...
  7. pmc Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study
    Joseph G Feldman
    SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, USA
    Am J Public Health 96:1060-5. 2006
    ..We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women...
  8. pmc Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
    Carlos M Vaamonde
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 22:222-31. 2006
    ..We conclude that higher baseline CD4 count and lower HIV RNA level were associated with poor immunologic response to HAART in women with virologic suppression for at least 6 months. Persistent low level viremia may also contribute...
  9. ncbi request reprint Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure
    Stephen J Gange
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 41:68-74. 2006
    ....
  10. pmc Increased circulating interleukin-7 levels in HIV-1-infected women
    Laura A Napolitano
    Gladstone Institute of Virology and Immunology, University of California at San Francisco, 94158, USA
    J Acquir Immune Defic Syndr 40:581-4. 2005
    ..0032) after controlling for CD4 count, age, and race. Given the important role of IL-7 in T-cell development and homeostasis, these findings suggest that higher IL-7 levels may contribute to higher CD4 counts in women...
  11. ncbi request reprint Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004
    Michael F Schneider
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD 21205, USA
    AIDS 19:2009-18. 2005
    ..To characterize changing survival patterns after development of clinical AIDS from 1984 to 2004, when different antiretroviral therapies were being introduced...
  12. ncbi request reprint The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women
    Kathryn Anastos
    Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 39:537-44. 2005
    ..To determine the association of race with clinical and laboratory outcomes after initiation of highly active antiretroviral therapy (HAART) in HIV-1-infected women in the United States...
  13. ncbi request reprint Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
    J Natl Cancer Inst 97:577-86. 2005
    ....
  14. ncbi request reprint Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy
    Jaclyn H Chu
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Am J Epidemiol 161:881-90. 2005
    ..517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART...
  15. ncbi request reprint Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    JAMA 293:1471-6. 2005
    ....
  16. ncbi request reprint Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study
    Nancy A Hessol
    Department of Medicine, University of California, San Francisco, CA 94122, USA
    Clin Infect Dis 44:287-94. 2007
    ..We examined temporal trends and risk factors for accident- and injury-related mortality among HIV-infected and -uninfected participants in the Women's Interagency HIV Study (WIHS) and the Multicenter AIDS Cohort Study (MACS)...
  17. ncbi request reprint Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women
    Judith A Cook
    Center on Mental Health Services Research and Policy, Department of Psychiatry M C 912, University of Illinois at Chicago, 1601 W Taylor Street M C 912, Chicago, IL 60612, USA
    Drug Alcohol Depend 89:74-81. 2007
    ..We examined the interaction of illicit drug use and depressive symptoms, and how they affect the subsequent likelihood of highly active antiretroviral therapy (HAART) use among women with HIV/AIDS...
  18. ncbi request reprint Does patient-provider racial/ethnic concordance influence ratings of trust in people with HIV infection?
    Nancy Lynn Sohler
    Sophie Davis Medical School, City University of New York, 138th Street and Convent Avenue, City College Campus, New York, NY 10031, USA
    AIDS Behav 11:884-96. 2007
    ....
  19. ncbi request reprint The association of bone mineral density with HIV infection and antiretroviral treatment in women
    Kathryn Anastos
    Montefiore Medical Centre, Bronx, NY, USA
    Antivir Ther 12:1049-58. 2007
    ..Low bone mineral density (BMD) has been reported in HIV-infected women and men...
  20. pmc Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
    Robert C Kaplan
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    AIDS 22:1615-24. 2008
    ..To assess the association of HIV infection, HIV disease parameters (including CD4+ T-cell counts, HIV viral load, and AIDS) and antiretroviral medication use with subclinical carotid artery atherosclerosis...
  21. pmc Awareness of hepatitis C infection among women with and at risk for HIV
    Mardge H Cohen
    CORE Center, Cook County Bureau of Health Services, Chicago, IL, USA
    J Gen Intern Med 22:1689-94. 2007
    ..Treatment guidelines recommend all HIV/HCV-co-infected persons be considered for hepatitis C virus (HCV) treatment, yet obstacles to testing and accessing treatment for HCV continue for women...
  22. doi request reprint Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women
    Jessica E Justman
    Department of Epidemiology, Columbia University, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 47:312-9. 2008
    ..Previous studies suggest that indicators of central adiposity such as waist-to-hip ratio (WHR) and waist circumference may be altered by HIV infection, antiretroviral treatment, or both...
  23. ncbi request reprint Good news for women living with HIV
    Kathryn Anastos
    J Infect Dis 196:971-3. 2007
  24. ncbi request reprint Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model
    Stephen R Cole
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Epidemiol 166:219-27. 2007
    ..In conclusion, the clinically important protective effect of HAART on dampening viral load appears to be rapid, present at CD4 cell counts greater than 350 cells/mm(3), and sustained beyond 6 years...
  25. ncbi request reprint Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens
    Kathryn Anastos
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 45:34-42. 2007
    ..The effects of HIV infection, highly active antiretroviral therapy (HAART), and specific antiretroviral agents on lipoproteins in women are not well described...
  26. pmc Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Brooklyn, New York, USA
    Fertil Steril 88:1645-52. 2007
    ..To determine whether HIV infection influences early follicular MIS levels, an early marker of ovarian aging...
  27. ncbi request reprint Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794 9640, USA
    J Low Genit Tract Dis 11:90-7. 2007
    ..To describe outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women with HIV...
  28. pmc Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Trop Med Int Health 13:870-9. 2008
    ..To describe temporal trends in baseline clinical characteristics, initial treatment regimens and monitoring of patients starting antiretroviral therapy (ART) in resource-limited settings...
  29. ncbi request reprint Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study
    Kathleen Mulligan
    University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 38:18-22. 2005
    ..0004 vs. HIV-negative). Thus, consistent with reports in men, lower levels of peripheral (leg) fat are seen in HIV-infected women on HAART, despite the high prevalence of obesity in this population...
  30. pmc HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation
    Kimdar Sherefa Kemal
    New York State Department of Health, Wadsworth Center, 120 New Scotland Avenue, Albany, NY 12208, USA
    Proc Natl Acad Sci U S A 100:12972-7. 2003
    ..These findings are relevant to the prevention and control of HIV-1 infection...
  31. ncbi request reprint HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois School of Medicine, Springfield, Illinois 62794, USA
    J Womens Health (Larchmt) 13:147-53. 2004
    ....
  32. ncbi request reprint Predictors of proteinuria and renal failure among women with HIV infection
    Lynda Anne Szczech
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Kidney Int 61:195-202. 2002
    ..This study examines the risk factors for proteinuria and renal failure in a large cohort of HIV-infected women not selected for the presence of renal disease...
  33. ncbi request reprint The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy
    Kathryn Anastos
    Montefiore Medical Center, Bronx, New York, USA
    Ann Intern Med 140:256-64. 2004
    ..The prognostic value of CD4+ cell counts and HIV-1 RNA levels attained after the initiation of highly active antiretroviral therapy (HAART) compared with before the initiation of HAART has not been well defined...
  34. ncbi request reprint Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study
    Lynn M Kirstein
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Room E 7007, Baltimore, MD 21205, U S A
    J Acquir Immune Defic Syndr 29:495-503. 2002
    ..The purpose of this study was to describe the variability in highly active antiretroviral therapy (HAART) regimens over time, the extent to which individuals switch, and the characteristics of those who are switching...
  35. ncbi request reprint Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models
    Stephen R Cole
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Epidemiol 158:687-94. 2003
    ..Standard Cox analysis failed to detect a clear net benefit, because it does not appropriately adjust for time-dependent covariates, such as HIV RNA level and CD4 cell count, that are simultaneously confounders and intermediate variables...
  36. ncbi request reprint Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women
    Helen E Cejtin
    Department of Obstetrics and Gynecology, Cook County Hospital, Chicago, IL, USA
    AIDS 17:1702-4. 2003
    ..There did not appear to be an association between hormonal contraception use and HIV-1-RNA levels in our study. There was a small increase in CD4 cell counts among hormonal users of doubtful clinical significance...
  37. ncbi request reprint Serum albumin is a powerful predictor of survival among HIV-1-infected women
    Joseph G Feldman
    State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203, USA
    J Acquir Immune Defic Syndr 33:66-73. 2003
    ..We now extend this to the use of serial measurements and single albumin values prior to initiation of highly active antiretroviral therapy...
  38. ncbi request reprint Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women
    Jessica E Justman
    Bronx Lebanon Hospital Center, New York 10457, USA
    J Acquir Immune Defic Syndr 32:298-302. 2003
    ..To assess the association between protease inhibitor (PI) use and the incidence of diabetes mellitus (DM) among participants in the Women's Interagency HIV Study...
  39. pmc Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy
    Mardge H Cohen
    Department of Medicine, Cook County Hospital, Chicago, Illinois, USA
    Am J Med 113:91-8. 2002
    ..To examine changes in the causes of death and mortality in women with human immunodeficiency virus (HIV) infection in the era of combination antiretroviral therapy...
  40. pmc CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women
    Sean Philpott
    Wadsworth Center, New York State Department of Health, Albany, New York 12208, USA
    J Infect Dis 187:569-75. 2003
    ..Because Delta 32 is rare in Africans and Asians, it seems plausible that differential genetic susceptibility, in addition to social and behavioral factors, may contribute to the rapid heterosexual spread of HIV-1 in Africa and Asia...
  41. ncbi request reprint The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts
    Michael J Silverberg
    Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
    Sex Transm Dis 29:427-35. 2002
    ..HIV infection and associated immunodeficiency are known to alter the course of human papillomavirus (HPV) infections and of associated diseases...
  42. ncbi request reprint Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women
    Judith A Cook
    Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois 60603, USA
    J Acquir Immune Defic Syndr 30:401-9. 2002
    ..These findings suggest that efforts to enhance women's access to psychological treatment may increase their use of the latest HIV therapies...
  43. ncbi request reprint Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University, Springfield, Illinois, 62794 9640, USA
    AIDS 18:281-6. 2004
    ..To determine frequency and outcomes of pregnancy in US women with HIV before and after introduction of highly active antiretroviral therapy (HAART)...
  44. ncbi request reprint Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy
    Kathryn Anastos
    Women s Interagency HIV Study, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 35:383-92. 2004
    ..If delayed-type hypersensitivity (DTH) response predicts clinical response in persons using highly active antiretroviral therapy (HAART), it may also prove useful in resource-poor settings...
  45. ncbi request reprint Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Acquir Immune Defic Syndr 37:1604-9. 2004
    ..Herpes zoster occurs at all CD4 cell counts in HIV-infected adults. It was hypothesized that even in the era of highly active antiretroviral therapy (HAART), zoster risk is higher in HIV-infected than uninfected women...
  46. ncbi request reprint Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    Obstet Gynecol 104:1077-85. 2004
    ..We sought to estimate rates of progression and regression of grade 1 cervical intraepithelial neoplasia (CIN 1) among women with human immunodeficiency virus (HIV)...
  47. ncbi request reprint Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies
    Stephen R Cole
    Department of Epidemiology, Johns Hopkins University, Baltimore, MD 21205, USA
    Stat Med 23:3351-63. 2004
    ..70; 95 per cent CI 0.35, 1.42). Methods presented here offer an approach to analysing prevalent cohort studies and provide procedures to maximize the usefulness of observational data...
  48. pmc CCR2 genotype and disease progression in a treated population of HIV type 1-infected women
    Sean Philpott
    Wadsworth Center, New York State Department of Health, Albany, NY, USA
    Clin Infect Dis 39:861-5. 2004
    ..No association was seen between CCR2 genotype and either disease progression or therapeutic response, suggesting that the benefits of treatment most likely overshadow the salutary effects of the V64I polymorphism...
  49. pmc Evolution of human immunodeficiency virus type 1 coreceptor usage during antiretroviral Therapy: a Bayesian approach
    Christina M R Kitchen
    Department of Biostatistics, UCLA School of Public Health, Los Angeles, CA 90095 1772
    J Virol 78:11296-302. 2004
    ..This model is not limited to analyses of HIV-1 but can be used to elucidate evolutionary processes for other organisms as well...
  50. pmc Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women
    Judith A Cook
    Mental Health Services Research Program, Department of Psychiatry, University of Illinois at Chicago, 104 S Michigan Ave, Suite 900, Chicago, IL 60603, USA
    Am J Public Health 92:82-7. 2002
    ..This study examined longitudinal trends in use of highly active antiretroviral therapy (HAART) among a cohort of HIV-positive participants in the Women' Interagency HIV Study...
  51. ncbi request reprint Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study
    Kiros Berhane
    Keck School of Medicine, University of Southern California, Los Angeles, CA 90089 9011, USA
    J Acquir Immune Defic Syndr 37:1245-52. 2004
    ..Anemia is common in HIV-infected individuals and may be associated with decreased survival...
  52. ncbi request reprint Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection
    Audrey L French
    CORE Center Cook County Hospital, Rush Medical College, Chicago, IL 60612, USA
    Clin Infect Dis 39:402-10. 2004
    ..65% to increases of 7.57% of the ULN per year; P values of.19-.71). Our findings lend support to assertions that antiretroviral therapy is safe for women with HCV infection...
  53. ncbi request reprint Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy
    Yolanda Barron
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    AIDS 18:1579-84. 2004
    ..To estimate the effect of discontinuing antiretroviral therapy (ART) on survival, among women who initiated highly active antiretroviral therapy (HAART)...
  54. ncbi request reprint Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women
    Howard Minkoff
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York, USA
    J Infect Dis 189:1821-8. 2004
    ..Among HIV-infected women, smoking is associated with a significantly higher prevalence and incidence of HPV infection. Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease...
  55. ncbi request reprint Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study
    Ann Khalsa
    University of Southern California, Los Angeles, California, USA
    AIDS 21:2539-41. 2007
    ..0001), and body mass index greater than 30 kg/m (P < 0.0001), whereas current pregnancy was protective (P < 0.04). HIV infection, CD4 cell count, HIV-1 viral load, and antiretroviral therapy were not associated with hypertension...
  56. doi request reprint Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women
    Marek J Nowicki
    Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
    AIDS Res Hum Retroviruses 24:163-8. 2008
    ..HIV-induced innate immune dysfunction may contribute to the eventual emergence of cancer in the setting of existing coinfections and altered immunosurveillance...
  57. doi request reprint Insulin-like growth factor axis and oncogenic human papillomavirus natural history
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 17:245-8. 2008
    ..07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV...
  58. ncbi request reprint Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women
    Tiffany G Harris
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 21:1933-41. 2007
    ..This study assessed the relationship of anergy test results with cervical infection by human papillomavirus (HPV) and cervical neoplasia in HIV-seropositive and seronegative women...
  59. ncbi request reprint Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women
    Howard D Strickler
    Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Natl Cancer Inst 95:1062-71. 2003
    ..To address this issue, we examined HPV test results from repeated study visits in the WIHS and from an independent study, the HIV Epidemiology Research Study (HERS)...
  60. pmc Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination
    Sean Philpott
    Wadsworth Center, New York State Department of Health, Albany, New York 12208, USA
    J Virol 79:353-63. 2005
    ....
  61. ncbi request reprint HIV-1 drug resistance in variants from the female genital tract and plasma
    Kimdar Sherefa Kemal
    Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
    J Infect Dis 195:535-45. 2007
    ..Human immunodeficiency virus type 1 (HIV-1) drug-resistance mutations may arise in a fraction of viral variants, and these variants may differ between compartments, including the genital tract and blood...
  62. ncbi request reprint Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction
    Helen E Cejtin
    John H Stroger Hospital of Cook County, Chicago, Illinois 60626, and University of California, San Francisco, San Francisco, California, USA
    Obstet Gynecol 108:1423-31. 2006
    ..To characterize ovarian failure and prolonged amenorrhea from other causes in women who are both human immunodeficiency virus (HIV) seropositive and seronegative...
  63. ncbi request reprint Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
    Monica Gandhi
    Department of Medicine, University of California, San Francisco 94122, USA
    AIDS 19:1885-96. 2005
    ....
  64. ncbi request reprint Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women
    Nicolas F Schlecht
    Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    J Gen Virol 86:2709-20. 2005
    ..If non-European variants are more oncogenic, the effect may involve a late stage in cervical tumorigenesis...
  65. ncbi request reprint Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women
    Mariana Lazo
    Johns Hopkins University Bloomberg School of Public Health, Epidemiology, Baltimore, MD 21205, USA
    Clin Infect Dis 45:1377-85. 2007
    ..Adherence to therapy is a dynamic behavior. However, few studies have identified factors associated with changes in adherence to highly active antiretroviral therapy (HAART) among men and women...